Neural toxicity induced by accidental intrathecal vincristine administration

Journal of Korean Medical Science

Volumn 14, Issue 6, 1999, Pages 688-692

  Kwack, Eun Kyung ^a   Kim, Dong Ja ^a   Park, Tae In ^a   Cho, Kab Rae ^b   Kwon, Il Hoon ^b   Sohn, Yoon Kyung ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b National Institute of Scientific Investigation   (South Korea)

Author keywords

Drug toxicity; Injection, spinal; Vincristine

Indexed keywords

ANTINEOPLASTIC AGENT; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BRAIN; CASE REPORT; CENTRAL NERVOUS SYSTEM; CYTOCHEMISTRY; DRUG EFFECT; FATALITY; HUMAN; INTRASPINAL DRUG ADMINISTRATION; MALE; MEDICATION ERROR; PATHOLOGY; PRESCHOOL CHILD; SPINAL CORD; SPINAL NERVE;

ANTINEOPLASTIC AGENTS; BRAIN; CENTRAL NERVOUS SYSTEM; CHILD, PRESCHOOL; FATAL OUTCOME; HISTOCYTOCHEMISTRY; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MEDICATION ERRORS; SPINAL CORD; SPINAL NERVES; VINCRISTINE;

EID: 0033254492     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.1999.14.6.688     Document Type: Article

References (14)

1. Schochet SS, Capt JR, Usar MC, Lampert PW, Earle KM. Neuronal changes induced by intrathecal vincristine sulfate. J Neuropathol Exp Neurol 1968; 27: 645-58.
2. Cardinali G, Enein MA. Studies on the antimitotic activity of leurocristine (vincristine). Blood 1963; 21: 102-10.
3. Fre E III, Whang J, Scoggins RB, Van Scott EJ, Rall DP, Ben M. The stathmokinetic effect of vincristine. Cancer Res 1964; 24: 1918-25.
4. Johnson IS, Armstrong JG, Gorman M, Burnett JP. The vinca alkaloids; a new class of oncolytic agents. Cancer Res 1963; 23: 1390-427.
5. Csuka O, Sugar J, Palyi I, Sowfai-Relle S. The mode of action of vinca alkaloids. Oncology 1980; 37 (Suppl 1): 83-7.
6. Whittaker JA. Coma associated with vincristine therapy. BMJ 1973; 4: 335-7.
7. Gaidys WG, Dickerman JD, Walters CL, Young PC. Intrathecal vincristine. Report of a fatal case despite CNS washout. Cancer 1983; 52: 799-801.
8. Bain PG, Lantos PL, Djurovic V, West I. Intrathecal vincristine: a fatal chemotherapeutic error with devastating central nervous system effects. J Neurol 1991; 238: 230-4.
9. Manelis J, Freundich E, Ezekiel E, Doron J. Accidental intrathecal vincristine administration. Report of a case. J Neurol 1982; 228: 209-13.
10. Shelanski ML, Wisniewski H. Neurofibrillary degeneration. Arch Neurol 1969; 20: 199-206.
11. Slyter H, Liwnicz B, Herrick MK, Mason R. Fatal myeloencephalopathy caused by intrathecal vincristine. Neurology 1980; 30: 867-71.
12. Shepherd DA, Steuber CP, Starling KA, Ferbach BJ. Accidental intrathecal administration of vincristine. Med Pediatr Oncol 1978; 5: 85-8.
13. Green LS, Donoso JA, Heller-Bettinger EY, Samson FE. Axonal transport disturbances in the vincristine induced peripheral neuropathy. Trans Am Neurol Assoc 1975; 100: 195-6.
14. Martin J, Mainwaring D. Coma and convulsions associated with vincristine therapy. BMJ 1973; 4: 782-4.